Cat. No. 1601
Biological ActivityPeptide containing the 'TGL' motif that corresponds to the C-terminus of the AMPA receptor GluR1 subunit.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Shi et al (2001) Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105 331. PMID: 11348590.
Hayashi et al (2000) Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 287 2262. PMID: 10731148.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Pep1-TGL include:
Cho et al (2012) Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit. J Neurosci 32 14165. PMID: 23055486.
McElligott et al (2010) Distinct forms of Gq-receptor-dependent plasticity of excitatory transmission in the BNST are differentially affected by stress. J Neuroimmunol 107 2271. PMID: 20133871.
Do you know of a great paper that uses Pep1-TGL from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Pep1-TGL, supplier, GluR1, subunit, C-terminus, peptide, Glutamate, AMPA, Receptors, iGluR, Ionotropic, Tocris Bioscience, AMPA Receptor products
Find multiple products by catalog number
New Products in this Area
NMDA receptor modulator; metabolite of Ketamine hydrochloride (Cat. No.3131)2S,6S-Hydroxynorketamine hydrochloride
Potent AMPA agonist; antidepressant2R,6R-Hydroxynorketamine hydrochloride
Potent AMPA agonist; lacks ketamine-related side effects(R)-Norketamine hydrochloride
NMDA receptor modulator; metabolite of Ketamine hydrochloride (Cat. No.3131).PEAQX tetrasodium salt
Potent NMDA receptor antagonist; NR2A selective
One Day Symposium
March 1, 2017
Amsterdam, The Netherlands